期刊文献+

他汀类药物治疗冠心病抗炎机制的研究进展 被引量:18

下载PDF
导出
摘要 冠状动脉内易损粥样斑块破裂、继发血栓形成是急性冠脉综合征的发生机制.而炎症反应是导致冠脉内结构性易损斑块向功能性易损斑块进展的重要环节.临床实验和基础研究表明:他汀类药物不但具有降低血浆胆固醇的主要作用,而且还涉及不依赖于其降血脂特性的非调脂抗动脉粥样硬化作用如抗炎性反应、促进斑块稳定及抑制血小板聚集、抑制血管平滑肌细胞增殖与迁移、促进血管平滑肌细胞凋亡、改善内皮功能等.基于以上作用机制,目前他汀类药物已成为冠心病治疗的基石.下面我们主要就他汀类药物治疗冠心病抗炎机制的最新研究进展作一综述。
出处 《中国现代医药杂志》 2009年第10期123-125,共3页 Modern Medicine Journal of China
基金 首都医科大学基础-临床科研合作基金(2007JL46) 北京安贞医院科技发展基金(20070213)
  • 相关文献

参考文献30

  • 1Kwak B, Mulhaupt F, Myit S, et al. statins as a newly recognized type of immunomodulator. Nat Med, 2000, 6(12):1399-1402.
  • 2Weitz-Schmidt G, Welzenbach K, Brinkmann V, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med, 2001,7 (6):687-692.
  • 3Veillard NR, Braunersreuther V, Arnaud C, et al. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis, 2006,188(1):51-58.
  • 4Allan MI, Rosario S, David JI. Vascular effects of HMG-CoA reductase inhibitors (statins) unrelated cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res,2001,49(3): 281-287.
  • 5Parmar KM, Nambudiri V, Dai G, et al. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem, 2005, 280(29):26714-26719.
  • 6Kothe H, Dalhoff K, Rupp J, et al. HMG-CoA reductase inhibitors modify the in flammatory response of human macrophage and endothelial cells infected with Chlamydia pneumoniae. Circulation, 2000,101:1760.
  • 7Clements JD, Jamali F. Pravastatin reverses the down-regulating effect of inflammation on beta-Adrenergic receptors: A diseasedrug interaction between inflammation, pravastatin, and propranolol. Vascul Pharmacol.2007, 46(1):52-59.
  • 8Ridker PM, Rifai N, Stampfer M J, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation,2000,101:1767-1772.
  • 9Bellosta S, Via D, Canavesi P, et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by marcophages. Arteroscler Thromb Vasc Biol, 1998, 18:1671.
  • 10McCarey DW, Melunes IB, Madhok R, et al. Trial of Atorvastatin in Rheumatoid Arthritis ( TARA): double-blind, randomized placebo-controlled trial. Lancet,2004,363:2015-2021.

同被引文献201

引证文献18

二级引证文献156

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部